Sermonix Pharmaceuticals Inc is a privately held biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and commercialization. Sermonix’s Lasofoxifene, entering phase 3, is thought to be a potent
third-generation selective estrogen receptor modulator (SERM) with high affinity for the estrogen receptor 1 (ESR1).
third-generation selective estrogen receptor modulator (SERM) with high affinity for the estrogen receptor 1 (ESR1).
Additional Info
- Banner Image URL: images/Sponsor/Sermonix_Logo.jpg
- Website URL: https://sermonixpharma.com
Published in
Bronze Sponsor
Latest from Dave Venus
Leave a comment
Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.
